ERIN L. RUSSELL - Corporate Board Profile

KADANT INC

Filing Date	Source Excerpt
2019-03-28	Ms. Russell, 45, has been a member of our board of directors since January 2019.
2020-03-26	Ms. Russell, 46, has been a member of our board of directors since January 2019, is the chair of our risk oversight and sustainability committee and is one of the board’s designated “audit committee financial experts.” ... The current members of the audit committee are Mr. Leonard (chairman), Dr. Albertine, Ms. Russell and Dr. Tully ... The current members of the risk oversight and sustainability committee are Ms. Russell (chair), Dr. Albertine, Mr. Leonard and Dr. Tully. ... The current members of the nominating and corporate governance committee are Dr. Tully (chairman), Dr. Albertine and Ms. Russell. ... Director Compensation for Fiscal 2019 ... Erin L. Russell ... $214,117.
2021-04-01	Erin L. Russell Ms. Russell, 47, has been a member of our board of directors since January 2019, is the chair of our risk oversight and sustainability committee and is one of the board’s designated “audit committee financial experts.” ... The current members of the audit committee are Mr. Leonard (chairman), Dr. Albertine, Ms. Russell and Dr. Tully ... The current members of the risk oversight and sustainability committee are Ms. Russell (chair), Dr. Albertine, Mr. Leonard and Dr. Tully ... The current members of the nominating and corporate governance committee are Dr. Tully (chairman), Dr. Albertine and Ms. Russell ... Director Compensation ... Erin L. Russell ... $238,115.
2022-03-30	Erin L. Russell Term Expires May 2024. Ms. Russell, 48, has been a member of our board of directors since January 2019, is the chair of our risk oversight and sustainability committee and is one of the board’s designated “audit committee financial experts.” ... Our directors who are not employees were paid the following cash compensation for serving on our board of directors in 2021: ... Erin L. Russell $72,500 fees earned or paid in cash, $169,926 stock awards, total $242,426.
2023-03-29	Erin L. Russell, 49, has been a member of our board of directors since January 2019, is the chair of our risk oversight and sustainability committee and is one of the board’s designated “audit committee financial experts.” ... The current members of the audit committee are Mr. Leonard (chairman), Dr. Albertine, and Ms. Russell ... The current members of the risk oversight and sustainability committee are Ms. Russell (chair), Dr. Albertine, Mr. Leonard and Ms. O'Mara. ... The following table provides compensation information for our non-employee directors in fiscal 2022. ... Erin L. Russell: Fees Earned or Paid in Cash: $80,000; Stock Awards: $169,916; Total: $249,916.
2024-03-27	Ms. Russell, 50, has been a member of our board of directors since January 2019, is the chair of our risk oversight and sustainability committee and is one of the board of directors' designated “audit committee financial experts.”
2025-03-26	Ms. Russell, 51, has been a member of our board of directors since January 2019, is the chair of our risk oversight and sustainability committee and is one of the board of directors' designated "audit committee financial experts." Ms. Russell currently serves as a director, chair of the audit committee and member of the compensation committee of eHealth, Inc., a publicly-traded leading online health insurance marketplace. Ms. Russell also currently serves as a director, member of the audit committee and member of the nominating and corporate governance committee of Modivcare, a publicly-traded technology-enabled healthcare services company. Ms. Russell is also a director of Fortrea, a publicly-traded contract research organization primarily serving customers in the pharmaceutical, biotechnology and medical device industries. Ms. Russell previously served as a director, member of the compensation committee and the chair of the audit committee of Tivity Health, Inc., a publicly traded provider of fitness, healthy life changing, and digital engagement solutions, from March 2020 to June 2022, when Tivity Health, Inc. ceased being publicly traded. She was a principal of Vestar Capital Partners, L.P. (Vestar), a private equity firm specializing in management buyouts, recapitalizations and growth equity investments, from August 2001 until April 2017. While at Vestar, Ms. Russell served on the boards of directors of a number of companies, including most recently as a director of DeVilbiss Healthcare LLC from 2012 until 2015 and as a director and a member of the audit committee of 21st Century Oncology Inc. from 2008 until 2016, including as the chair of the audit committee until 2014, both private healthcare companies. She also served as a director of DynaVox Inc., a communications device manufacturer, from 2004 until 2014, including serving as the chair of its audit committee until its initial public offering in 2010. Ms. Russell is also a chair of the board of St. Thomas Aquinas Catholic School of Fairfield, Connecticut, where she has served since 2018, and has served on the advisory boards of McIntire School of Commerce, where she is the current chair, since 2016 and the Jefferson Scholars Foundation at the University of Virginia since 2008. We believe Ms. Russell’s qualifications to serve on our board of directors include her financial, operating, mergers and acquisitions, and management experience gained through working with a variety of private equity portfolio companies, her knowledge and experience gained through service on the boards of other companies, and her high level of financial literacy and experience with capital and credit markets gained through her investment experience.